Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System
During the first year of the coronavirus disease 2019 (COVID-19) pandemic, prevention measures included quarantining and facility closures. Because cancer screening is dependent on interventions in facilities, the extent of the COVID-19 impact on screening was questioned. A claims registry from a la...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-01-01
|
| Series: | Healthcare |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9032/10/2/264 |
| _version_ | 1797479749438668800 |
|---|---|
| author | Amar H. Kelkar Jing Zhao Shu Wang Christopher R. Cogle |
| author_facet | Amar H. Kelkar Jing Zhao Shu Wang Christopher R. Cogle |
| author_sort | Amar H. Kelkar |
| collection | DOAJ |
| description | During the first year of the coronavirus disease 2019 (COVID-19) pandemic, prevention measures included quarantining and facility closures. Because cancer screening is dependent on interventions in facilities, the extent of the COVID-19 impact on screening was questioned. A claims registry from a large health system was queried for colorectal and prostate cancer screening. A screening gap and screening loss ratio were calculated by comparing 2020 screening to historical reference years. All cancer screenings decreased in the first four months of the pandemic. Colorectal cancer screening returned to baseline in the latter six months of 2020. Prostate cancer screening exceeded baseline in the latter six months, but with a lesser gain than previous years. Populations disproportionately affected by decreased cancer screening included men and black people. To catch-up after the initial deficit in screening, it is estimated that the rate of colorectal cancer screening needs to increase by 50%. |
| first_indexed | 2024-03-09T21:50:16Z |
| format | Article |
| id | doaj.art-d14163f3c03f41309046fd0d0216cfb7 |
| institution | Directory Open Access Journal |
| issn | 2227-9032 |
| language | English |
| last_indexed | 2024-03-09T21:50:16Z |
| publishDate | 2022-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Healthcare |
| spelling | doaj.art-d14163f3c03f41309046fd0d0216cfb72023-11-23T20:09:07ZengMDPI AGHealthcare2227-90322022-01-0110226410.3390/healthcare10020264Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health SystemAmar H. Kelkar0Jing Zhao1Shu Wang2Christopher R. Cogle3Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USADepartment of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32610, USADepartment of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32610, USADivision of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USADuring the first year of the coronavirus disease 2019 (COVID-19) pandemic, prevention measures included quarantining and facility closures. Because cancer screening is dependent on interventions in facilities, the extent of the COVID-19 impact on screening was questioned. A claims registry from a large health system was queried for colorectal and prostate cancer screening. A screening gap and screening loss ratio were calculated by comparing 2020 screening to historical reference years. All cancer screenings decreased in the first four months of the pandemic. Colorectal cancer screening returned to baseline in the latter six months of 2020. Prostate cancer screening exceeded baseline in the latter six months, but with a lesser gain than previous years. Populations disproportionately affected by decreased cancer screening included men and black people. To catch-up after the initial deficit in screening, it is estimated that the rate of colorectal cancer screening needs to increase by 50%.https://www.mdpi.com/2227-9032/10/2/264cancer screeningcolorectal cancerprostate cancerCOVID-19health disparitieshealth policy |
| spellingShingle | Amar H. Kelkar Jing Zhao Shu Wang Christopher R. Cogle Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System Healthcare cancer screening colorectal cancer prostate cancer COVID-19 health disparities health policy |
| title | Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System |
| title_full | Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System |
| title_fullStr | Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System |
| title_full_unstemmed | Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System |
| title_short | Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System |
| title_sort | impact of the covid 19 pandemic on colorectal and prostate cancer screening in a large u s health system |
| topic | cancer screening colorectal cancer prostate cancer COVID-19 health disparities health policy |
| url | https://www.mdpi.com/2227-9032/10/2/264 |
| work_keys_str_mv | AT amarhkelkar impactofthecovid19pandemiconcolorectalandprostatecancerscreeninginalargeushealthsystem AT jingzhao impactofthecovid19pandemiconcolorectalandprostatecancerscreeninginalargeushealthsystem AT shuwang impactofthecovid19pandemiconcolorectalandprostatecancerscreeninginalargeushealthsystem AT christopherrcogle impactofthecovid19pandemiconcolorectalandprostatecancerscreeninginalargeushealthsystem |